FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis

Share this post

Everolimus tablets for oral suspension become the first approved therapy specifically indicated for the treatment of partial-onset seizures associated with tuberous sclerosis complex.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply